talent4boards.com - Talent4Boards Team
Talent4Boards - Great Talent builds Great Boards – USA, MA – Navitor Pharmaceuticals, Inc., a biopharmaceutical company developing novel medicines targeting the activation of mTORC1, today announced that Paul Friedman, MD, former President & Chief Executive Officer of Incyte Corporation, has joined the Navitor Board of Directors as an independent Director.… => more Navitor Pharmaceuticals appoints Paul Friedman to the Board as Independent Director
posted by friends: (3)
@ProfessionalDir: Navitor Pharmaceuticals appoints Paul Friedman to #BoardOfDirectors as Independent Director ow.ly/OqIQV #NonExec #biotech
@WholeBoardDev: Navitor Pharmaceuticals appoints Paul Friedman to #BoardOfDirectors as Independent Director ow.ly/OqIQV #NonExec #biotech
@daviddoughty: Navitor Pharmaceuticals appoints Paul Friedman to #BoardOfDirectors as Independent Director ow.ly/OqIQV #NonExec #biotech
posted by followers of the list: (0)
via Corporate Governance - articles, news, resourceshttp://www.talent4boards.com/navitor-pharmaceuticals-appoints-paul-friedman-board-independent-director/
No comments:
Post a Comment